Gravis G. - list of publications

List of records

Display:

CUSTIRSEN IN COMBINATION WITH DOCETAXEL AND PREDNISONE FOR PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (SYNERGY TRIAL): A PHASE 3, MULTICENTRE, OPEN-LABEL, RANDOMISED TRIAL

Article

Chi K.N., Gleave M., Higano C.S., Blumenstein B., Ferrero J.M., Reeves J., Feyerabend S., Stenzl A., Gravis G., Merseburger A.S., Bergman A.M., Mukherjee S.D., Zalewski P., Saad F., Jacobs C., De Bono J.S.

The Lancet Oncology. Vol. 18. 2017. P. 473-485

AFLIBERCEPT VERSUS PLACEBO IN COMBINATION WITH DOCETAXEL AND PREDNISONE FOR TREATMENT OF MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (VENICE): A PHASE 3, DOUBLE-BLIND RANDOMISED TRIAL

Article

Tannock I.F., Fizazi K., Ivanov S., Thellenberg Karlsson, Flechon A., Skoneczna I., Orlandi F., Gravis G., Matveev V., Bavbek S., Gil T., Viana L., Aren O., Karyakin O., Elliott T., Birtle A., Magherini E., Hatteville L., Petrylak D., Tombal B., Rosenthal M.

The Lancet Oncology. Vol. V14. 2013. P. 760-768

Page 1 of 1. Items from 1 to 2 of 2

Other authors

Orlandi F.

Records: 1

Matveev V.

Records: 2